[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2437400A1 - Polypeptides therapeutiquement actifs ou leurs sels d'addition d'acides, et procede pour leur production - Google Patents

Polypeptides therapeutiquement actifs ou leurs sels d'addition d'acides, et procede pour leur production

Info

Publication number
FR2437400A1
FR2437400A1 FR7924078A FR7924078A FR2437400A1 FR 2437400 A1 FR2437400 A1 FR 2437400A1 FR 7924078 A FR7924078 A FR 7924078A FR 7924078 A FR7924078 A FR 7924078A FR 2437400 A1 FR2437400 A1 FR 2437400A1
Authority
FR
France
Prior art keywords
production
therapeutically active
acid
acid adding
active polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7924078A
Other languages
English (en)
Other versions
FR2437400B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordisk Insulinlaboratorium
Original Assignee
Nordisk Insulinlaboratorium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlaboratorium filed Critical Nordisk Insulinlaboratorium
Publication of FR2437400A1 publication Critical patent/FR2437400A1/fr
Application granted granted Critical
Publication of FR2437400B1 publication Critical patent/FR2437400B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/645—Secretins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'INVENTION CONCERNE L'OBTENTION DE POLYPEPTIDES. ILS ONT POUR FORMULE A-X-B-Y-C X: AMINO-ACIDE (GLU, ASP); Y: AMINO-ACIDE (ARG, LYS, HIS); Z: H OU PETIT GROUPE PROTECTEUR; B: LIAISON, AMINO-ACIDE SIMPLE OU PEPTIDE (JUSQU'A 10AMINO-ACIDES); C: NRR (H, ALKYLE, CYCLOALKYLE) OU OR (ALKYLE, CYCLOALKYLE, BENZYLE) OU AMINO-ACIDE. CES POLYPEPTIDES, OU LEURS SELS D'ADDITION D'ACIDES, INHIBENT LA SECRETION DE L'INSULINE PAR LES ILOTS DE LANGERHANS ET EXALTENT LE METABOLISME DU GLUCOSE.
FR7924078A 1978-09-28 1979-09-27 Polypeptides therapeutiquement actifs ou leurs sels d'addition d'acides, et procede pour leur production Granted FR2437400A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK430478 1978-09-28

Publications (2)

Publication Number Publication Date
FR2437400A1 true FR2437400A1 (fr) 1980-04-25
FR2437400B1 FR2437400B1 (fr) 1984-06-15

Family

ID=8132257

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7924077A Granted FR2437399A1 (fr) 1978-09-28 1979-09-27 Polypeptides, ou sels d'addition d'acides de ceux-ci, therapeutiquement actifs et procede de preparation de ces composes
FR7924078A Granted FR2437400A1 (fr) 1978-09-28 1979-09-27 Polypeptides therapeutiquement actifs ou leurs sels d'addition d'acides, et procede pour leur production

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7924077A Granted FR2437399A1 (fr) 1978-09-28 1979-09-27 Polypeptides, ou sels d'addition d'acides de ceux-ci, therapeutiquement actifs et procede de preparation de ces composes

Country Status (16)

Country Link
US (1) US4356119A (fr)
JP (2) JPS5569550A (fr)
AT (1) AT375338B (fr)
AU (2) AU533684B2 (fr)
BE (2) BE879087A (fr)
CA (2) CA1140116A (fr)
CH (2) CH648567A5 (fr)
DE (2) DE2939109A1 (fr)
ES (2) ES484928A1 (fr)
FI (2) FI68245C (fr)
FR (2) FR2437399A1 (fr)
GB (2) GB2031436B (fr)
IT (2) IT1125421B (fr)
NL (2) NL7907187A (fr)
NO (2) NO148922C (fr)
SE (2) SE7907939L (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3400118A (en) * 1966-05-27 1968-09-03 Squibb & Sons Inc Intermediates in the preparation of secretin

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA798855A (en) * 1968-11-12 Bernardi Luigi Process for preparing a new undecapeptide
CA616330A (en) * 1961-03-14 Schwyzer Robert Polypeptide and derivatives thereof and process for their manfuacture
CA685075A (en) * 1964-04-21 Schwyzer Robert Polypeptides and process for their manufacture
GB1064417A (en) * 1963-12-09 1967-04-05 Kyowa Hakko Kogyo Kk Process for the preparation of copolypeptides
US3832337A (en) * 1970-07-28 1974-08-27 Squibb & Sons Inc Peptide enzyme inhibitors
US3856770A (en) * 1972-03-08 1974-12-24 Akzona Inc Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
NL175988C (nl) * 1972-05-24 1985-02-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat dat afgeleid is van een de aminozuren 4-10 omvattend, fragment van adrenocorticotroop hormoon als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
NL175618C (nl) * 1972-07-15 1984-12-03 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.
DE2315271C3 (de) * 1973-03-27 1975-09-11 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen L- Norleucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel
GB1532211A (en) * 1974-10-25 1978-11-15 Wellcome Found Lh-rh peptide analogues
US3975365A (en) * 1975-01-27 1976-08-17 G. D. Searle & Co. Inhibitory octapeptides angiotensin II
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
US4058512A (en) * 1975-04-28 1977-11-15 Ab Kabi Synthetic peptides having growth promoting activity
US4024121A (en) * 1976-01-27 1977-05-17 Schally Andrew Victor (Pyro)-Glu-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHR and intermediates
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4110321A (en) * 1976-07-12 1978-08-29 Folkers Karl Synthetic tridecapeptide [Gln4 ]-neurotensin having hormonal activity
US4086220A (en) * 1976-08-09 1978-04-25 G. D. Searle & Co. Fragments of secretin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3400118A (en) * 1966-05-27 1968-09-03 Squibb & Sons Inc Intermediates in the preparation of secretin

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EXBK/65 *
EXBK/74 *

Also Published As

Publication number Publication date
JPS5569550A (en) 1980-05-26
NO148922C (no) 1984-01-11
ES484928A1 (es) 1980-07-01
FI793001A (fi) 1980-03-29
SE7907938L (sv) 1980-03-29
AT375338B (de) 1984-07-25
NO148923B (no) 1983-10-03
IT7926111A0 (it) 1979-09-28
US4356119A (en) 1982-10-26
IT7926112A0 (it) 1979-09-28
FI68245B (fi) 1985-04-30
FR2437399B1 (fr) 1983-01-28
FR2437399A1 (fr) 1980-04-25
ATA634679A (de) 1983-12-15
DE2939135A1 (de) 1980-04-17
NO793111L (no) 1980-03-31
IT1125421B (it) 1986-05-14
SE7907939L (sv) 1980-03-29
ES484926A1 (es) 1980-07-01
GB2031436A (en) 1980-04-23
CA1158640A (fr) 1983-12-13
FI68245C (fi) 1985-08-12
GB2031435B (en) 1982-11-10
NL7907187A (nl) 1980-04-01
CH648567A5 (de) 1985-03-29
DE2939109A1 (de) 1980-04-10
AU533684B2 (en) 1983-12-08
JPS5576849A (en) 1980-06-10
GB2031436B (en) 1982-10-20
NO148923C (no) 1984-01-11
FR2437400B1 (fr) 1984-06-15
AU5124679A (en) 1980-04-03
AU526149B2 (en) 1982-12-16
NO793112L (no) 1980-03-31
FI793002A (fi) 1980-03-29
FI68244C (fi) 1985-08-12
BE879086A (fr) 1980-03-28
NO148922B (no) 1983-10-03
BE879087A (fr) 1980-03-28
FI68244B (fi) 1985-04-30
CA1140116A (fr) 1983-01-25
CH648568A5 (de) 1985-03-29
AU5124579A (en) 1980-04-03
NL7907188A (nl) 1980-04-01
IT1125422B (it) 1986-05-14
GB2031435A (en) 1980-04-23

Similar Documents

Publication Publication Date Title
ATE33835T1 (de) Verbindung mit antibronchopneumopathischer wirkung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
CA2093806A1 (fr) Methode de traitement ou de prevention du diabete de type 1 par l'administration orale d'insuline
EP0285008A3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
ES499870A0 (es) Un procedimiento para la preparacion de derivados de indano
BG43865A3 (en) Method for preparing of 1, 3- disubstituted 2- oxyindols
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
FR2437400A1 (fr) Polypeptides therapeutiquement actifs ou leurs sels d'addition d'acides, et procede pour leur production
PT86998A (pt) Process for the preparation of a pharmaceutical compound containing as active ingredient the acid 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4h-pyrano (3,2-g) quinoline-2,8-dicarboxylic
EP0134582A3 (fr) Peptides, procédé de leur préparation et compositions pharmaceutiques
ES8308833A1 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
ZA891769B (en) Heterocyclic compounds
MY101747A (en) Dihydroorotic acids derivative, processes for preparing the same
CA2038025A1 (fr) Derives de l'alkylenedioxybenzene optiquement actifs et leur utilisation a des fins therapeutiques
DE69001710T2 (de) Merkaptoacylaminosäure.
FI894119A0 (fi) Menetelmä isoseriini-N,N-dietikkahapon trinatriumsuolan valmistamiseksi
GB1319772A (en) Succinimides
FR2434814A1 (fr) Bromo-2 ergosinine et ses sels d'addition d'acides utiles comme medicaments et un procede de leur preparation
CA2022323A1 (fr) Excretion d'ions potassium par des derives de l'acide prostanoique
EP0528997B1 (fr) Derives de disulfure d'acides mercapto-acylamino
DE3461924D1 (en) 1,3-bis(dimethylamino)-2-propyl-4-chlorophenoxyacetate, its addition salts, process for its production and pharmaceutical preparations containing the afore-mentioned compounds
ES8701146A1 (es) Procedimiento para la preparacion de sales del acido d-6 me-toxi-alfametil-2-naftalenacetico
FR2540515B1 (fr) Procede de preparation d'acides amines optiquement actifs par synthese enzymatique
IT1173763B (it) Derivati dell'acido 3-mercapto-2-oxo-1-pirrolidinacetico,procedimento di preparazione e composizioni farmaceutiche che li contengono
ES8403111A1 (es) Un procedimiento para la preparacion de pirbuterol.
PT74320A (en) Process for preparing new ammonium salts pharmaceutical preparations containing these compounds and their use

Legal Events

Date Code Title Description
ST Notification of lapse